サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1226959

中南米の水産養殖用ワクチン市場の2028年までの予測- 地域別分析- ワクチンタイプ別、種別、投与経路別

South & Central America Aquaculture Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type of Vaccine, Species, and Route of Administration
出版日: | 発行: The Insight Partners | ページ情報: 英文 118 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
中南米の水産養殖用ワクチン市場の2028年までの予測- 地域別分析- ワクチンタイプ別、種別、投与経路別
出版日: 2023年02月21日
発行: The Insight Partners
ページ情報: 英文 118 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の水産養殖用ワクチン市場は、2022年の1,147万米ドルから2028年には2,307万米ドルに成長すると予測されます。2022年から2028年までのCAGRは12.4%で成長すると推定されます。

新規ワクチンの開発が中南米の水産養殖用ワクチン市場を牽引する

近年、水産養殖は大きな経済革命を遂げました。科学の進歩により、様々な感染症に対する新規かつ効果的なワクチンの開発・設計や既存ワクチンの改良のための基礎・応用研究分野に新たな道が開かれました。ワクチンとワクチン学の最近の発展は、ワクチンがまだ不足している真菌や寄生虫を含む魚類の病原体と戦うための新しいワクチン候補を発見するために行われています。そのため、中南米の水産養殖用ワクチン市場は、予測期間中、新規のワクチン開発によって活性化すると予想されます。

中南米の水産養殖用ワクチン市場の概要

中南米の水産養殖用ワクチン市場には、ブラジル、アルゼンチン、チリ、およびその他の地域が含まれます。同地域の水産養殖用ワクチン市場は、予測期間中に成長機会を得られると期待されています。中南米の水産養殖用ワクチン市場は、同地域における魚類の感染症ケースの増加や魚類の消費量の増加などの要因により、成長が期待されています。世界銀行のデータによると、ブラジルはラテンアメリカで最大であり、2億1300万人以上の人口と約1兆4,500億米ドル（1兆3300億ユーロ）のGDPを誇っています。そのブラジルが輸出する水産物は、わずか3億6,500万米ドル（3億3,400万ユーロ）ですが、ブラジル貿易投資振興庁（Apex-Brasil）は、この状況を変えようとしています。ブラジル養殖協会（PeixeBR）と提携したEmbrapaのデータによると、2021年のブラジル養殖魚輸出量は9,900トンで、2020年に比べて49%増加しました。出荷による収入は78％増の2,070万米ドルとなっています。

ブラジルの魚の主な輸出先は3つで、合わせて輸出の80％以上を占めました。米国が1位で64％、コロンビアが2位で9％の参加でした。米国への輸出品目は、冷凍のホールフィッシュが620万米ドル、次いで生鮮または冷蔵のフィレ（500万米ドル）、冷凍フィレ（200万米ドル）です。このように、上記の要因から、ブラジルの水産養殖用ワクチン市場は予測期間中に成長すると予想されます。

中南米の水産養殖用ワクチン市場の収益と2028年までの予測（金額）

中南米の水産養殖用ワクチン市場のセグメンテーション

中南米の水産養殖用ワクチン市場は、ワクチンタイプ、種、投与経路、国別に区分されます。

ワクチンタイプに基づき、中南米の水産養殖用ワクチン市場は、生ワクチンと不活化ワクチン、その他のワクチンに分類されます。2022年には、不活化ワクチン分野が最大の市場シェアを占めています。

種別では、中南米の水産養殖用ワクチン市場は、ティラピア、トラウト、サーモン、エビ、その他に分けられます。2022年にはサーモン部門が最大の市場シェアを占めました。

投与経路に基づき、中南米の水産養殖用ワクチン市場は、注射ワクチン、浸漬ワクチン、経口ワクチンに区分されます。2022年には、注射ワクチン部門が市場で最大のシェアを占めました。

国別に見ると、中南米の水産養殖用ワクチン市場は、ブラジル、アルゼンチン、その他南米に分類されます。2022年の水産養殖用ワクチン市場シェアは、ブラジルが独占しています。

Elanco Animal Health Inc、HIPRA SA、Merck &Co Inc.、Phibro Animal Health Corp、Tecnovax SA、VETERQUIMICA SA、およびZoetis Inc.は、中南米の水産養殖用ワクチン市場で活動している主要企業です。

目次

第1章 イントロダクション

第2章 中南米の水産養殖用ワクチン市場- 重要なポイント

第3章 調査手法

  • カバレッジ
  • 2次調査
  • 1次調査

第4章 水産養殖用ワクチン市場-市場情勢

  • 南米のPEST分析
  • 専門家の見解

第5章 水産養殖用ワクチン市場-主要市場力学

  • 市場促進要因
    • 成長する水産養殖産業
    • 水生動物由来食品への需要の高まり
  • 市場抑制要因
    • ワクチン認可のための厳しい規制方針とワクチンコストの高さ
  • 今後の動向
    • 新規ワクチンの開発
  • 影響度分析

第6章 水産養殖用ワクチン市場-中南米分析

第7章 中南米の水産養殖用ワクチン市場収益と2028年までの予測：ワクチンタイプ別

  • 中南米の水産養殖用ワクチン市場2021年・2028年売上高シェア（%）：ワクチンタイプ別
  • 生ワクチンのみ
  • 不活性化ワクチン
  • その他のワクチン

第8章 中南米の水産養殖用ワクチン市場の分析と2028年までの予測：種別

  • 中南米の水産養殖用ワクチン市場2021年・2028年（%）：種別
  • ティラピア
  • トラウト
  • サーモン
  • エビ類
  • その他

第9章 中南米の水産養殖用ワクチン市場の収益と2028年までの予測：投与経路別

  • 中南米の水産養殖用ワクチン市場収入シェア2021年・2028年（%）：投与経路別
  • 注射ワクチン
  • 浸漬型ワクチン
  • 経口ワクチン

第10章 中南米の水産養殖用ワクチン市場-収益と2028年までの予測-国別分析

    • 南米
      • ブラジル
      • アルゼンチン
      • チリ
      • その他南米諸国

第11章 水産養殖用ワクチン市場- 業界情勢

  • 水産養殖用ワクチン市場の成長戦略
  • 有機的な成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • HIPRA SA
  • Merck & Co Inc
  • Zoetis Inc
  • VETERQUIMICA SA
  • Phibro Animal Health Corp
  • Elanco Animal Health Inc
  • Tecnovax SA

第13章 付録

図表

List Of Tables

  • Table 1. Brazil: Aquaculture Vaccines Market, by Type of Vaccines - Revenue and Forecast to 2028 (USD Million)
  • Table 2. Brazil: Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (USD Million)
  • Table 3. Brazil: Aquaculture Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 4. Argentina: Aquaculture Vaccines Market, by Type of Vaccines - Revenue and Forecast to 2028 (USD Million)
  • Table 5. Argentina: Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (USD Million)
  • Table 6. Argentina: Aquaculture Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 7. Chile: Aquaculture Vaccines Market, by Type of Vaccines - Revenue and Forecast to 2028 (USD Million)
  • Table 8. Chile: Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (USD Million)
  • Table 9. Chile: Aquaculture Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 10. Rest of SAM: Aquaculture Vaccines Market, by Type of Vaccines - Revenue and Forecast to 2028 (USD Million)
  • Table 11. Rest of SAM: Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (USD Million)
  • Table 12. Rest of SAM: Aquaculture Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 13. Recent Organic Growth Strategies in Aquaculture Vaccines Market
  • Table 14. Recent Inorganic Growth Strategies in the Aquaculture Vaccines Market
  • Table 15. Glossary of Terms

List Of Figures

  • Figure 1. SAM Aquaculture Vaccines Market Segmentation
  • Figure 2. SAM Aquaculture Vaccines Market, by Country
  • Figure 3. SAM Aquaculture Vaccines Market Overview
  • Figure 4. Inactivated Vaccine Segment Held Largest Share of Type Segment in SAM Aquaculture Vaccines Market
  • Figure 5. Argentina is Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. SAM: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. SAM Aquaculture Vaccines Market Impact Analysis of Drivers and Restraints
  • Figure 9. SAM Aquaculture Vaccines Market Revenue and Forecast to 2028 (USD Million)
  • Figure 10. SAM Aquaculture Vaccines Market Revenue Share, by Type of Vaccine 2021 & 2028 (%)
  • Figure 11. Live Vaccines: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Inactivated Vaccines: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Other Vaccines: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. SAM Aquaculture Vaccines Market, by Species 2021 & 2028 (%)
  • Figure 15. Tilapia: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Trout: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Salmon: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Shrimps: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Others: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. SAM Aquaculture Vaccines Market Revenue Share, by Route of Administration 2021 & 2028 (%)
  • Figure 21. Injection Vaccines: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Immersions Vaccines: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Oral Vaccines: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. SAM: Aquaculture Vaccines Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 25. SAM: Aquaculture Vaccines Market, by Country, 2021 & 2028 (%)
  • Figure 26. Brazil: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 27. Argentina: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 28. Chile: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 29. Rest of SAM: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 30. Growth Strategies in Aquaculture Vaccines Market
目次
Product Code: BMIRE00028134

The South & Central America aquaculture vaccines market is expected to grow from US$ 11.47 million in 2022 to US$ 23.07 million by 2028. It is estimated to grow at a CAGR of 12.4% from 2022 to 2028.

Development of Novel Vaccines is Driving the South & Central America Aquaculture Vaccines Market

In recent years, aquaculture has attained a major economic revolution. Advancements in science have paved new avenues in basic and applied research areas for developing and designing novel and effective vaccines and improving existing vaccines for various infectious diseases. Recent developments in vaccines and vaccinology are done to discover new vaccine candidates to combat fish pathogens, including mycotic and parasitic agents, for which vaccines are still lacking. Therefore, novel vaccine developments are expected to boost for South & Central America aquaculture vaccines market during the forecast period.

South & Central America Aquaculture Vaccines Market Overview

SAM aquaculture vaccines market includes Brazil, Argentina, Chile, and Rest of SAM. The market for aquaculture vaccines in the region is expected to have growth opportunities during the forecast period. The aquaculture vaccines market in the SAM region is expected to grow owing to factors such as, an increase in cases of infectious diseases in fishes in the region and increasing fish consumption drive the market in the region. According to World Bank data, Brazil is a giant in Latin America: it boasts a population of more than 213 million people and a GDP of some USD 1.45 trillion (EUR 1.33 trillion). It exports only about USD 365 million (EUR 334 million) in seafood, but the Brazilian Trade and Investment Promotion Agency, Apex-Brasil, is looking to change that. Brazilian farmed fish exports totaled 9,900 tons in 2021, 49% more than in 2020, according to Embrapa data in partnership with the Brazilian Fish Farming Association (PeixeBR). Revenue from shipments increased by 78% to US$20.7 million.

The three main destinations for Brazilian fish accounted together for more than 80% of exports. The United States ranked first, with 64% of participation, and Colombia ranked second, with 9% participation. The main item on the list of exports to the US was frozen whole fish, totaling US$ 6.2 million, followed by fresh or chilled fillets (US$ 5 million) and frozen fillets (US$ 2 million). Thus, owing to the above-mentioned factors the aquaculture vaccines market in Brazil is expected to grow during the forecast period.

South & Central America Aquaculture Vaccines Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Aquaculture Vaccines Market Segmentation

The South & Central America aquaculture vaccines market is segmented into type of vaccine, species, route of administration, and country.

Based on type of vaccine, the South & Central America aquaculture vaccines market, is segmented into live vaccines, inactivated vaccines, other vaccines. The inactivated vaccines segment held the largest market share in in 2022.

Based on species, the South & Central America aquaculture vaccines market is divided into tilapia, trout, salmon, shrimps, and others. The salmon segment held the largest share of the market in 2022.

Based on route of administration, the South & Central America aquaculture vaccines market, is segmented into injection vaccines, immersions vaccines, and oral vaccines. The injection vaccines segment held the largest share of the market in 2022.

Based on country, the South & Central America aquaculture vaccines market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the aquaculture vaccines market share in 2022.

Elanco Animal Health Inc; HIPRA SA; Merck & Co Inc.; Phibro Animal Health Corp; Tecnovax SA; VETERQUIMICA SA; and Zoetis Inc.; are the leading companies operating in the South & Central America aquaculture vaccines market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America aquaculture vaccines market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America aquaculture vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the aquaculture vaccines market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 SAM Aquaculture Vaccines Market - by Type of Vaccine
    • 1.3.2 SAM Aquaculture Vaccines Market - by Species
    • 1.3.3 SAM Aquaculture Vaccines Market - by Route of Administration
    • 1.3.4 SAM Aquaculture Vaccines Market - by Country

2. SAM Aquaculture Vaccines Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. SAM Aquaculture Vaccines Market - Market Landscape

  • 4.1 Overview
  • 4.2 SAM PEST Analysis
  • 4.3 Expert's Opinion

5. SAM Aquaculture Vaccines Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Aquaculture Industry
    • 5.1.2 Surging Demand for Aquatic Animal-Derived Food Products
  • 5.2 Market Restraints
    • 5.2.1 Strict Regulatory Policies for Approval of Vaccines and High Cost of Vaccines
  • 5.3 Future Trends
    • 5.3.1 Development of Novel Vaccines
  • 5.4 Impact Analysis

6. Aquaculture Vaccines Market - SAM Analysis

  • 6.1 SAM: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)

7. SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 - by Type of Vaccine

  • 7.1 Overview
  • 7.2 SAM Aquaculture Vaccines Market Revenue Share, by Type of Vaccine 2021 & 2028 (%)
  • 7.3 Live Vaccines
    • 7.3.1 Overview
    • 7.3.2 Live Vaccines: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Inactivated Vaccines
    • 7.4.1 Overview
    • 7.4.2 Inactivated Vaccines: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Other Vaccines
    • 7.5.1 Overview
    • 7.5.2 Other Vaccines: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

8. SAM Aquaculture Vaccines Market Analysis and Forecasts to 2028 - by Species

  • 8.1 Overview
  • 8.2 SAM Aquaculture Vaccines Market, by Species 2021 & 2028 (%)
  • 8.3 Tilapia
    • 8.3.1 Overview
    • 8.3.2 Tilapia: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Trout
    • 8.4.1 Overview
    • 8.4.2 Trout: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Salmon
    • 8.5.1 Overview
    • 8.5.2 Salmon: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Shrimps
    • 8.7.1 Overview
    • 8.7.2 Shrimps: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

9. SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 - by Route of Administration

  • 9.1 Overview
  • 9.2 SAM Aquaculture Vaccines Market Revenue Share, by Route of Administration 2021 & 2028 (%)
  • 9.3 Injection Vaccines
    • 9.3.1 Overview
    • 9.3.2 Injection Vaccines: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Immersions Vaccines
    • 9.4.1 Overview
    • 9.4.2 Immersions Vaccines: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Oral Vaccines
    • 9.5.1 Overview
    • 9.5.2 Oral Vaccines: SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

10. SAM Aquaculture Vaccines Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Overview
    • 10.1.1 SAM: Aquaculture Vaccines Market, by Country, 2021 & 2028 (%)
      • 10.1.1.1 Brazil: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 Brazil: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.1.1.3 Brazil: Aquaculture Vaccines Market, by Type of Vaccines, 2019-2028 (USD Million)
        • 10.1.1.1.4 Brazil: Aquaculture Vaccines Market, by Species, 2019-2028 (USD Million)
        • 10.1.1.1.5 Brazil: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (USD Million)
      • 10.1.1.2 Argentina: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Argentina: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.1.2.3 Argentina: Aquaculture Vaccines Market, by Type of Vaccines, 2019-2028 (USD Million)
        • 10.1.1.2.4 Argentina: Aquaculture Vaccines Market, by Species, 2019-2028 (USD Million)
        • 10.1.1.2.5 Argentina: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (USD Million)
      • 10.1.1.3 Chile: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Chile: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.1.3.3 Chile: Aquaculture Vaccines Market, by Type of Vaccines, 2019-2028 (USD Million)
        • 10.1.1.3.4 Chile: Aquaculture Vaccines Market, by Species, 2019-2028 (USD Million)
        • 10.1.1.3.5 Chile: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (USD Million)
      • 10.1.1.4 Rest of SAM: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Rest of SAM: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.1.4.3 Rest of SAM: Aquaculture Vaccines Market, by Type of Vaccines, 2019-2028 (USD Million)
        • 10.1.1.4.4 Rest of SAM: Aquaculture Vaccines Market, by Species, 2019-2028 (USD Million)
        • 10.1.1.4.5 Rest of SAM: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (USD Million)

11. Aquaculture Vaccines Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Aquaculture Vaccines Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 HIPRA SA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Merck & Co Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Zoetis Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 VETERQUIMICA SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Phibro Animal Health Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Elanco Animal Health Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Tecnovax SA
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms